Cargando…

β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy

INTRODUCTION: Tumor-initiating cells (TICs) are rare, stem-like, and highly malignant. Although intravenous hepatitis B and C immunoglobulins have been used for HBV and HCV neutralization in patients, their tumor-inhibitory effects have not yet been examined. Hepatitis B immunoglobulin (HBIG) therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagawa, Chad, Kadlera Nagaraj, Manjunatha, Hernandez, Juan Carlos, Uthay Kumar, Dinesh Babu, Shukla, Vivek, Machida, Risa, Schüttrumpf, Jörg, Sher, Linda, Farci, Patrizia, Mishra, Lopa, Tahara, Stanley M., Ou, Jing-Hsiung James, Machida, Keigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516572/
https://www.ncbi.nlm.nih.gov/pubmed/37744383
http://dx.doi.org/10.3389/fimmu.2023.1204907

Ejemplares similares